|
Market Closed -
Nasdaq
21:00:00 14/08/2025 BST
|
5-day change | 1st Jan Change | ||
| 100.99 USD | +0.01% |
|
-.--% | - |
| Market Cap | 3.32B 2.85B 2.66B 2.44B 4.59B 317B 4.67B 31.39B 12.29B 159B 12.47B 12.2B 526B | P/E 2023 |
-317x | P/E 2024 | 69.3x |
|---|---|---|---|---|---|
| Enterprise Value | 3.48B 2.98B 2.79B 2.56B 4.81B 332B 4.88B 32.87B 12.87B 167B 13.06B 12.77B 551B | EV / Sales 2023 |
1.55x | EV / Sales 2024 | 1.33x |
| Free-Float |
-
| Yield 2023 * |
-
| Yield 2024 | - |
| 30/09/25 | A CEO's Playbook For Navigating Crisis And Building Trust (Video) | AQ |
| 29/07/25 | Amedisys: Q2 Earnings Snapshot | AQ |
| 29/07/25 | Amedisys : Second Quarter 2025 Earnings Release Supplemental Slides | PU |
| 29/07/25 | Amedisys Reports Second Quarter 2025 Financial Results | AQ |
| 23/04/25 | Amedisys: Q1 Earnings Snapshot | AQ |
| 1 day | +0.01% |
| 3 years | 82.15 |  | 101.02 |
| 5 years | 69.36 | | 188.88 |
| 10 years | 34.58 | | 325.12 |
| Manager | Title | Age | Since |
|---|---|---|---|
Scott Ginn
DFI | Director of Finance/CFO | 57 | 05/10/2017 |
Keith Blanchard
CTO | Chief Tech/Sci/R&D Officer | - | - |
Denise Bohnert
CMP | Compliance Officer | 48 | 31/12/2016 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 14/08/25 | Issuer sale | Director | 9,818 | 0.0300% | ||
| 14/08/25 | Issuer sale | Director | 9,818 | 0.0300% | ||
| 14/08/25 | Issuer sale | Chief Executive Officer | 520,347 | 1.5886% |
| 2023 | 2024 | |
|---|---|---|
| Net sales | 2.24B 1.92B 1.79B 1.64B 3.09B 214B 3.14B 21.14B 8.28B 107B 8.4B 8.21B 354B | 2.35B 2.01B 1.88B 1.73B 3.25B 224B 3.3B 22.2B 8.69B 113B 8.82B 8.63B 372B |
| Net income | -9.75M -8.36M -7.81M -7.16M -13.47M -932M -13.69M -92.12M -36.07M -467M -36.6M -35.8M -1.54B | 43.23M 37.08M 34.63M 31.77M 59.74M 4.13B 60.73M 409M 160M 2.07B 162M 159M 6.85B |
| Net Debt | 361M 309M 289M 265M 499M 34.48B 507M 3.41B 1.34B 17.29B 1.35B 1.33B 57.18B | 156M 134M 125M 115M 216M 14.92B 219M 1.47B 578M 7.48B 586M 573M 24.73B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- AMED Stock
Select your edition
All financial news and data tailored to specific country editions
